Form 4: ClearPoint Neuro CFO D'Alessandro Settles Restricted Stock Units
SEC Form 4 Filing
Danilo D'Alessandro, CFO of ClearPoint Neuro, settled restricted stock units and sold shares to cover tax obligations on March 12, 2025.
Summary
- On March 12, 2025, Danilo D'Alessandro, the CFO of ClearPoint Neuro, Inc. (CLPT), settled 16,313 restricted stock units, receiving common stock.
- He also disposed of 8,284 shares of common stock at a price of $13.18 to satisfy tax withholding obligations related to the vesting of the restricted stock units.
- Following these transactions, D'Alessandro directly owns 70,746 shares of ClearPoint Neuro common stock and 65,253 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine transaction related to executive compensation and doesn't necessarily indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates activity by the CFO of ClearPoint Neuro, which is typical for executives receiving stock-based compensation.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the CFO's personal holdings and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: settlement of restricted stock units and sale of shares for tax obligations. |
| 03/14/2025 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.